fk-838 has been researched along with Body-Weight* in 1 studies
1 other study(ies) available for fk-838 and Body-Weight
Article | Year |
---|---|
A new adenosine subtype-1 receptor antagonist, FK-838, attenuates salt-induced hypertension in Dahl salt-sensitive rats.
We investigated the effects of the adenosine type-1 receptor antagonist FK-838 on salt-induced hypertension in Dahl-Sea salt-sensitive (Dahl S) rats. Dahl S rats fed a high-salt (4% NaCl) diet for 4 weeks were treated with FK-838 or hydrochlorothiazide for 4 weeks and alterations in kidney function and morphologic changes were assessed. FK-838 attenuated the development of hypertension in Dahl S rats, and caused a decrease in aortic weight in a dose dependent fashion. The adenosine antagonist did not produce any detectable metabolic disturbance. The blood pressure reduction by FK-838 was associated with attenuation of glomerular and arterial injury in the kidney. The renal protective effect of FK-838 treatment was associated with a reduction of plasma renin activity and plasma aldosterone concentration. In contrast, the thiazide diuretic, which produced almost the same blood pressure reduction as FK-838, did not attenuate renal damage. These data indicate that adenosine A1 receptor antagonism reduces salt-induced hypertension and the consequent renal injuries. Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Creatinine; Eicosanoids; Hydrochlorothiazide; Hypertension; Kidney; Kidney Function Tests; Organ Size; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Inbred Strains; Sodium Chloride | 1995 |